• World
    • United States
    • UK
    • Australia
    • Europe
    • World
    • India
  • Politics
  • Business
  • Science
  • Sports
  • History & Art
  • Shorts
  • Videos
Friday, September 22, 2023
  • Login
  • Register
News 100
  • World
    • United States
    • UK
    • Australia
    • Europe
    • World
    • India
  • Politics
  • Business
  • Science
  • Sports
  • History & Art
  • Shorts
  • Videos
No Result
View All Result
News 100
No Result
View All Result
Home India

Centre restricts syringe exports for 3 months to aid COVID-19 fight

by
October 9, 2021
in India
0 0
0
Centre restricts syringe exports for 3 months to aid COVID-19 fight
0
SHARES
27
VIEWS


But classes of syringes not used for COVID-19 vaccines can be sent abroad.

Related posts

Assam: The wild mushrooms killing India tea garden workers

Assam: The wild mushrooms killing India tea garden workers

May 20, 2022
Greens fear draft rules on 11 species of trees will spell environmental disaster 

4 injured, several trapped as part of tunnel on J&K highway collapses in Ramban

May 20, 2022

The Government has imposed a three-month restriction on exports of three categories of syringes to ensure that there is enough to “improve domestic uptake and availability”. However complying with demands from local industry, it has allowed exports of classes of syringes not used for COVID-19 vaccines.

Most syringes used in COVID-19 vaccination have a capacity of 0.3 ml though bigger ones are also used.

Following a meeting on Saturday on the progress of COVID-19 vaccination, Union Health Minister Mansukh Mandaviya told senior health officials in states, that the “immediate milestone” in India’s COVID-19 vaccination journey was completing administration of 100 crore doses. India has so far administered 94 crore vaccine doses.

The three categories of syringes that will be subject to this “quantitative restriction” on exports are 0.5 ml/ 1ml AD (auto-disable) syringes, 0.5 ml/1 ml/2 ml/3 ml disposable syringes, 1ml/2 ml/3 ml RUP (re-use prevention) syringes.

Earlier this week, the Directorate General of Foreign Trade (DGFT), a Commerce Ministry body, issued a notification that the export policy for syringes, with or without needles, has been amended from “free” to “restricted”. The notification drew protests from the All India Syringes and Needles Manufacturing Association (AISNMA) which also said that it “tarnished” India’s reputation as credible global supplier and manufacturing hub for syringes.

However, following the Union Health Ministry’s statement on Saturday, the All India Syringes and Needles Manufacturing Association (AISNMA) “welcomed” the easing on syringes not used for COVID-19 vaccination.

“So the syringes that are not used for COVID vaccination like Insulin Syringes, 0.3 ML, 5 ML and larger sizes of 10 ML, 20 ML & 50 ML etc will be allowed to be exported. This is definitely going to be a relief for India’s international buyers and will majorly help to maintain India’s reputation as credible global supplier and our relationship built over the years with them,” Rajiv Nath, President, AISNMA, said in a statement.

Mr. Nath, the Managing Director of Hindustan Syringes & Medical Devices (HMD) Ltd. said his company on Friday offered the Centre 10 crore syringes in addition to their outstanding orders of 23.2 crore syringes for delivery by January end. The Centre, in response, had reportedly ordered 7.5 crore syringes.

“We again request the Union government to place orders for AD syringes with the manufacturers in India well in advance so that the latter could ramp up supplies. Clarity should be given of India’s quarterly needs by MoH&FW for calendar year 2022 as we can’t plan on a 2-4 months window horizon basis. To ramp up capacity, we need an order confirmation at least nine months to a year in advance,” said Mr. Nath.

India is currently producing more vaccines than its production of Auto Disable (AD) syringes — the preferred choice for COVID-19 vaccination. However, vaccination can be given also by Standard Disposable Syringes with a 0.5 ML / 1 ML / 2 ML or 3 ML Syringes. Between the 20 manufacturers of AISNMA, India’s manufacturing capacity is over 500 million syringes per month and usually 30-50% is spare capacity.

At Saturday’s meeting, Uttar Pradesh had pointed out the “comparatively limited supply of Covaxin” and its shorter span between the doses as a reason why vaccination wasn’t proceeding as fast as it could, said a statement from the Press Information Bureau.

Previous estimates in April by Bharat Biotech had claimed that production would scale to over six crore doses a month by September but actual supply is much lower. Chairman Bharat Biotech Krishna Ella had said in September that output would be scaled to 5.5 crore doses by October.

For India to meet its goal to fully inoculate all adults by the year end, it needs to vaccinate over a crore every day but has consistently averaged a little less than 80 lakh a day since the 2.5 crore doses on September 17.

Mr Mandaviya said more than 8 crore doses were available with States. Many States were nearing “saturation of coverage” in urban areas, he added.



Source link

Tags: AISNMAAll India Syringes and Needles Manufacturing Associationcovid vaccinationMansukh Mandaviyasyringe

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

News 100

We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc.

Follow us on social media:

Recent News

  • European Council President says it’s time to put multilateralism back solid ground
  • Funding woes continue to plague UN Palestine refugee agency
  • Survivors of Libya floods grapple with trauma

Category

  • Australia
  • Business
  • China
  • Europe
  • History
  • History & Art
  • India
  • Science
  • Shorts
  • Sports
  • UK
  • Uncategorized
  • United States
  • World

Recent News

European Council President says it’s time to put multilateralism back solid ground

European Council President says it’s time to put multilateralism back solid ground

September 22, 2023
Funding woes continue to plague UN Palestine refugee agency

Funding woes continue to plague UN Palestine refugee agency

September 22, 2023
  • World
  • Politics
  • Business
  • Science
  • Sports
  • History & Art
  • Shorts
  • Videos

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • World
    • United States
    • UK
    • Australia
    • Europe
    • World
    • India
  • Politics
  • Business
  • Science
  • Sports
  • History & Art
  • Shorts
  • Videos

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In